Dear SAPC Provider,
As has been discussed at prior Provider Meetings, the Service and Bed Availability Tool (SBAT) is a web-based tool that will provide a dashboard of available substance use services throughout Los Angeles County so that users (e.g., patients, providers, and other stakeholders) can identify appropriate specialty substance use disorder (SUD) providers in order to access services. The SBAT will be generally accessible to anyone with internet access, and will have filtering capability so users can filter through SUD providers according to offered level of cares/languages/services so that referrals are matched to patient need. The SBAT is relevant to all SUD providers operating within SAPC’s network, and once launched, will be promoted as one of the primary ways to identify appropriate SUD providers for referrals made into SAPC’s SUD provider network.
Feedback on Time-Limited SBAT Demo Link: http://sapccis.ph.lacounty.gov/sbat_demo/
SAPC wants to give its provider network an opportunity to provide feedback on this tool, keeping in mind that the target users of the SBAT are the general public and providers who are seeking SUD services. The above SBAT demo link will be available for a period of seven (7) calendar days, so please review this time-limited SBAT demo link and submit your comments to Krystal Ho at email@example.com by June 27, 2017.
After June 27th, this demo link will be deactivated as we work to finalize the SBAT tool, so please submit your feedback within the specified timeframe. The more detailed and organized your feedback, the more likely we will be able to make necessary adjustments.
In relation to the SBAT survey results, monitoring staff will be contacting you shortly to confirm the data submitted. It is critical that you confirm and validate this information as soon as possible to ensure the data in SBAT is accurate.
Thank you in advance for your cooperation as we work together to advance SUD treatment across the County.
Chief, Contract Services Division
Substance Abuse Prevention and Control, Contract Services Division
Los Angeles County Department of Public Health
1000 South Fremont Avenue, Building A-9 East, Third Floor
Alhambra, CA 91803
626) 299-4532 Tel
626) 299-7226 Fax
A message to Universal Condom Work Group Members and Supporters:
Recently I received a troubling email from one of our colleagues at the AIDS Foundation Chicago, Jessica Terlikowski. She expressed that she and her colleagues had a concerning call with Veru Health Care. Veru Health Care is the company that bought Female Health Company; they manufacture FC2, the only FDA approved female condom currently available in the United States. Jessica shared that Veru Healthcare is working toward revoking the commercial availability of FC2. This means no longer being able to buy FC2 through Walgreen’s stores, CVS, or online pharmacy retailers. Additionally the company is looking to move into a prescription based model. A prescription is not currently required for FC2 use but by moving to this new model Veru hopes they can increase the price point to $119.47 for a box of 12 condoms (yes you read that correctly). I have also learned that Veru will no longer rely on distributers like Total Access Group to sell FC2 to Public Health Departments, CBOs and clinics. Veru Healthcare will move to distribute FC2 in-house via sales representatives.
The reasons given for their turn, they claim are due to the lack of profitability in the retail market. The company claims they aren’t making a sizable profit from the commercial sale of FC2 and they need to make changes. However, during the call they stated they remain committed to ensuring FC2 is available to those seeking them.
The Universal Condom Work Group is disheartened by these recent findings. We understand the difference between access and ease of access for our communities. When individuals have the ease of access to effective pregnancy/ STI prevention, they are more likely to engage in using them. The Universal Condom Work Group has seen progress from our labor in the past two years. I have seen FC2 availability increase as more community clinics and health programs obtain FC2 for their clients. Most recently Los Angeles County Department of Public Health moved to include female condoms in the upcoming The Los Angeles County Comprehensive HIV Plan. This non gender specific inclusion of ‘internal condoms’ ensures those engaging in receptive sexual activities have increased prevention options. To date, over 200 healthcare providers, public health investigators, nurses, and health educators in Los Angeles County have attended the trainings the Work Group has hosted. In turn they share the benefits of FC2 with their staff and clients. However there is so much more work to be done.
As most of you know I have been at the forefront of this fight for Los Angeles, beating the drum highlighting a tool that provides dual protection, can enhance sexual pleasure, and empowers receptive partners to take the lead in protecting themselves.
The proposed rollback of availability would be a barrier to those needing FC2 the most. There is additional concern that at the proposed cost, insurers would be less likely to cover FC2, leaving women without premium insurance unable to obtain them if desired. Providers might be less likely to discuss them as an option if they know clients will be unable to actually get their hands on them.
Having the power of choice allows different people the ability to make the best decisions for themselves in any given situation. I believe women and any other person engaging in receptive intercourse should have HIV/STI prevention options available to them that are affordable, easy to access and suitable to their personal needs. I agree with the AIDS Foundation of Chicago and the National Female Condom Coalition that “these decisions are outrageous and unacceptable as they take a critical prevention option out of the hands of both women living with and vulnerable to HIV.” The advocates of the National Female Condom Coalition are organizing a collective response to these proposed changes. Your voices will be a critical addition as we move forward. I will continue to keep you abreast of developments as they roll out.
Additionally as these changes take shape, I encourage you to procure as many FC2 for your patients and clients before any price changes take effect or we begin to experience difficulty in getting them from our distributors. Contact me for assistance in finding FC2.
SAMHSA Headlines—Your one-stop source for the latest from SAMHSA.
Over $70 million is available in grants over multiple years to help communities and health care providers prevent opioid overdose deaths and provide treatment for opioid use disorder.
Administered through SAMHSA, these funds will be made available through the following three grants:
- Medication-Assisted Treatment and Prescription Drugs—Opioid Addiction: Up to $28 million to five grantees to increase access of medication-assisted treatment (MAT) for opioid use disorder. MAT combines behavioral therapy and U.S. Food and Drug Administration (FDA)-approved medication.
- First Responders: Up to $41.7 million over 4 years to approximately 30 grantees to train and provide resources for first responders and members of other key community sectors on carrying and administering an FDA-approved product for emergency treatment of known or suspected opioid overdose.
- Improving Access to Overdose Treatment: Up to $1 million over 5 years to one grantee to expand availability to overdose reversal medications in health care settings and to establish protocols to connect patients who have experienced a drug overdose with appropriate treatment.
The purpose of these cooperative agreements is to implement suicide prevention and intervention programs for individuals who are age 25 or older, that are designed to raise awareness of suicide, establish referral processes, and improve care and outcomes for such individuals who are at risk for suicide.
From 2010 to 2013, emergency department visits where alcohol was the only substance involved accounted for 78.8 percent of all underage alcohol misuse-related visits, and visits that combined drugs and alcohol accounted for 21.2 percent of underage alcohol misuse-related emergency department visits.
According to a new report, 3.3 percent of all Americans age 12 or older (8.7 million people) used some form of smokeless tobacco in the past month. In this report, smokeless tobacco refers to both chewing tobacco and snuff. The report also shows that an estimated 1 million Americans in this age group used smokeless tobacco for the first time in the past year.Resources
Advancing Best Practices in Behavioral Health for Asian American, Native Hawaiian, and Pacific Islander Boys and Men
This report describes selected best behavioral health practices and programs for Asian American, Native Hawaiian, and Pacific Islander boys and young men.
June 13, 2017
In June 2016, SAMHSA’s SSI/SSDI Outreach, Access, and Recovery (SOAR) Technical Assistance Center began a series of informal monthly calls designed to help support SOAR efforts across the country. Join these conference calls to learn how to implement local steering committees or if you have questions related to SOAR applications.
This series highlights efforts underway to stimulate collaborations that address trauma.
Substance Abuse and Mental Health Services Administration
5600 Fishers Lane | Rockville, MD 20857 | 1-877-SAMHSA-7 (1-877-726-4727) | http://www.samhsa.gov
SAMHSA is a public health agency within the U.S. Department of Health and Human Services. Its mission is to reduce the impact of substance abuse and mental illness on America’s communities.
New Grant Opportunity
The Office of Minority Health (OMH) at the U.S. Department of Health and Human Services is accepting applications for a cooperative agreement for the Empowered Communities for a Healthier Nation Initiative. This program seeks to reduce the impact of significant health disparities among racial and ethnic minorities and/or disadvantaged populations by implementing evidence-based strategies. The program aims to serve residents in communities disproportionately impacted by the opioid epidemic, childhood/adolescent obesity, and serious mental health disorders. OMH expects to fund up to 16 cooperative agreements with up to $350,000 per year for up to 3 years.
|Learn More About This Funding Opportunity Announcement and How To Apply.|
Miss yesterday’s amazing Coping with Hope: HIV in Uncertain Times conference?
Watch all of the livestreamed videos from yesterday’s conference here. We will also post ancillary information & handouts.
Source: Coping with Hope conference